Chemical_Library_Compound_list.xls
XLS spreadsheet 82 KB Posted
- Attached to
- Chemical Library of 216 Specific Compounds Federal contract opportunity
- Solicitation number
- NIHDA201800458
About this file
Chemical Library List of 216 Compounds
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Compound list (216)
| # | Supplier | Catalogue number | NIH Index# | Drug Names | Search Criteria | Compound State | Unit | QTY |
| 1 | ACINTS | ACI-01405 | 62 | DPN-205-734 | Cc1nc(O)c(cc1-c1ccc(cc1)C#N)C#N | N/A | 10 mg | 1 |
| 2 | AK Scientific | O621 | 192 | AICA orotate Orazamide orotate | OC(=O)c1c[nH]c(=O)[nH]c1=O | powder | 1 g | 1 |
| 3 | AK Scientific | J90633 | 49 | CTI-01 Ethyl pyruvate | CCOC(=O)C(C)=O | liquid | 25 g | 1 |
| 4 | AK Scientific | A427 | 64 | Isobutyramide VX-366 | CC(C)C(N)=O | powder | 25 g | 1 |
| 5 | AK Scientific | Y1809 | 241 | Sodium tungstate | O[W](O)(=O)=O | powder | 10 g | 1 |
| 6 | AK Scientific | B706 | 199 | C-751 | CCOC(=O)c1cnc[nH]1 | powder | 1 g | 1 |
| 7 | AK Scientific | R096 | 207 | Can-C N-Acetylcarnosine | CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O |r| | powder | 5 g | 1 |
| 8 | AK Scientific | H367 | 225 | BDD BFD DDB alpha-DDB Bifendate Biphenyldimethyldicarboxylate | COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC | powder | 1 g | 1 |
| 9 | AK Scientific | A443 | 134 | Modrastane Modrefen Modrenal Trilostane (BAN; USAN; Rec INN) Win-25540 | CC12CCC3C(CCC45OC4C(O)=C(CC35C)C#N)C1CCC2O |c:13| | powder | 10 mg | 1 |
| 10 | AK Scientific | X5843 | 169 | Hypo STS Sodium thiosulfate | [Na+].[Na+].[O-]S([O-])(=O)=S | powder | 100 g | 1 |
| 11 | AK Scientific | N532 | 110 | Cp2TiCl2 MKT-4 Titanocene dichloride | Cl[Ti]Cl.[CH]1[CH][CH][CH][CH]1.[CH]1[CH][CH][CH][CH]1 |^1:3,4,5,6,7,8,9,10,11,12| | crystal | 5 g | 1 |
| 12 | AK Scientific | C910 | 69 | Cabaletta Thealoz T-2762 Trehalose | O.O.OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O | powder | 25 g | 1 |
| 13 | AK Scientific | F678 | 75 | Dipeptamin Dipeptiven Glutamine dipeptide | C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O |r| | powder | 1 g | 1 |
| 14 | AK Scientific | O375 | 72 | Barnidipine hydrochloride (Rec INNM) Mepirodipine hydrochloride Cyress Hypoca Vasexten EU-730 YM-09730-5 YM-730 | Cl.COC(=O)C1=C(C)NC(C)=C([C@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@H]1CCN(Cc2ccccc2)C1 |c:4,9| | powder | 100 mg | 1 |
| 15 | AK Scientific | 9886AA | 141 | 4-Butylresorcinol Rucinol | CCCCc1ccc(O)cc1O | powder | 1 g | 1 |
| 16 | AK Scientific | K341 | 219 | 710674S Cloconazole hydrochloride Croconazole hydrochloride (Rec INNM) Pilzcin | Cl.Clc1cccc(COc2ccccc2C(=C)n2ccnc2)c1 | powder | 25 mg | 1 |
| 17 | AK Scientific | R239 | 200 | Azulen Azulenal Azulene SN Azunol Azupromin Garmastan Guaiazulenesulfonate sodium Sodium azulene sulfonate (JAN) Sodium gualenate (Rec INN) | [Na+].CC(C)c1ccc(C)c2c(cc(C)c2c1)S([O-])(=O)=O | powder | 25 mg | 1 |
| 18 | AK Scientific | H975 | 60 | Hexopal Inositol hexanicotinate | O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H]1OC(=O)c1cccnc1)c1cccnc1 | powder | 1 g | 1 |
| 19 | AK Scientific | M754 | 142 | 254-S NSC-375101D Aqupla Nedaplatin (Rec INN) | N.N.O=C1CO[Pt]O1 | powder | 10 mg | 1 |
| 20 | AK Scientific | 4062AB | 171 | ALT-711 Alagebrium chloride (USAN; Rec INN) | [Cl-].Cc1sc[n+](CC(=O)c2ccccc2)c1C | powder | 1 g | 1 |
| 21 | AK Scientific | E309 | 205 | HMR-3647 RU-66647 Ketek Levviax Telithromycin (Prop INN; USAN) | CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(c3)-c3cccnc3)C(=O)O[C@]12C)OC |r| | powder | 10 mg | 1 |
| 22 | AK Scientific | J10464 | 174 | Chromax Chromium picolinate | [Cr+3].[O-]C(=O)c1ccccn1.[O-]C(=O)c1ccccn1.[O-]C(=O)c1ccccn1 | powder | 100 mg | 1 |
| 23 | AK Scientific | Q717 | 204 | Cefcamate pivoxil hydrochloride Cefcapene pivoxil hydrochloride (Rec INNM) Flomox Flumax S-1108 | O.Cl.CC\C=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)c1csc(N)n1 |c:16| | powder | 250 mg | 1 |
| 24 | AK Scientific | V1307 | 53 | Corebeta Onoact Rapibloc LDLL-600 ONO-LDL-50 Ono-1101 AOP-200704 Landiolol hydrochloride (Prop INNM) | Cl.CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1 | powder | 10 mg | 1 |
| 25 | AK Scientific | X7595 | 231 | '572 1349572 GSK-1349572A S-349572 S/GSK-1349572 Dolutegravir sodium (Prop INNM; USAN) Tivicay | C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12 |r| | powder | 25 mg | 1 |
| 26 | AK Scientific | X3281 | 40 | BEA-2180 BEA-2180 BR | CN1[C@H]2C[C@@H](C[C@@H]1C=C2)OC(=O)C(O)(c1cccs1)c1cccs1 |c:8,TLB:0:1:5.4.3:7.8| | solid | 5 mg | 1 |
| 27 | AK Scientific | Y1367 | 228 | Asunaprevir (Prop INN; USAN) BMS-650032 Sunvepra | COc1cnc(O[C@@H]2C[C@H](N(C2)C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)N[C@@]2(C[C@@H]2C=C)C(=O)NS(=O)(=O)C2CC2)c2cc(Cl)ccc12 | powder | 10 mg | 1 |
| 28 | AK Scientific (made-to-order) | SYN5159 | 183 | BMOV VO(ma)2 | O=[V++].Cc1occc(=O)c1[O-].Cc1occc(=O)c1[O-] | N/A | 50 mg | 1 |
| 29 | AK Scientific (made-to-order) | KMA0102 | 194 | C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(C)=O |r,c:11,t:7| | N/A | 50 mg | 1 | |
| 30 | Angene | AGN-PC-0WAGDI | 98 | OC(=O)[C@@H]1C[C@@H](Cc2cccc(F)c2)CN1 |r| | N/A | 250 mg | 1 | |
| 31 | Angene | AGN-PC-0JPLKF | 158 | ALN-101 EML-676 IDD-000676-01 IDD-676 Lidorestat (USAN; Rec INN) | OC(=O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2ccccc12 | N/A | 1 g | 1 |
| 32 | Angene | AGN-PC-0Q7IGJ | 48 | Dy-EOB-DTPA Gadoxetic acid | CCOc1ccc(C[C@@H](CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)cc1 |r| | N/A | 1 g | 1 |
| 33 | Aronis | BBC/529 | 36 | Troventol | [I-].CCC(CO)(C(=O)OC1CC2CCC(C1)[N+]2(C)C)c1ccccc1 | N/A | 1 g | 1 |
| 34 | Aronis | BBC/538 | 189 | Cl.COc1noc(COc2ccccc2OCC(O)CNC(C)(C)C)n1 | N/A | 1 g | 1 | |
| 35 | Axon Medchem | 2460 | 83 | 2110183 ASB-183 GSK-2110183 GSK-2110183C GSK-21110183 Afuresertib (USAN; Rec INN) | Cn1ncc(Cl)c1-c1cc(sc1Cl)C(=O)NC(CN)Cc1cccc(F)c1 | N/A | 25 mg | 1 |
| 36 | Axon Medchem | 1480 | 57 | L-888839 MK-0524 Laropiprant (Prop INN; USAN) | [Na+].CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC([O-])=O)c3n(Cc3ccc(Cl)cc3)c12 |r| | N/A | 25 mg | 1 |
| 37 | Axon Medchem | 1549 | 6 | SSR-504734 | Cl.FC(F)(F)c1cccc(C(=O)N[C@H]([C@@H]2CCCCN2)c2ccccc2)c1Cl |r| | N/A | 5 mg | 1 |
| 38 | Axon Medchem | 2533 | 97 | Hydroxypioglitazone MIN-102 U-91322 | Cl.CC(O)c1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 | N/A | 25 mg | 1 |
| 39 | Axon Medchem | 2583 | 168 | BI-1467335 PXS-4728 PXS-4728A | Cl.CC(C)(C)NC(=O)c1ccc(OC\C(CN)=C\F)cc1 | N/A | 5 mg | 1 |
| 40 | Axon Medchem | 2841 | 39 | COTI-2 | S=C(N\N=C1\CCCc2cccnc12)N1CCN(CC1)c1ccccn1 | N/A | 10 mg | 1 |
| 41 | BIDE PHARMATECH | BD6876 | 96 | Boronophenylalanine L-BPA SPM-011 | N[C@@H](Cc1ccc(cc1)B(O)O)C(O)=O |r| | N/A | 250 mg | 1 |
| 42 | BIDE PHARMATECH | BD631136 | 23 | (+)-N-Desmethylzopiclone (S)-DMZ SEP-174559 | Cl.Clc1ccc(nc1)N1C(OC(=O)N2CCNCC2)c2nccnc2C1=O | N/A | 100 mg | 1 |
| 43 | BIDE PHARMATECH | BD3887 | 164 | NCC(=O)N[C@@H](CCC(N)=O)C(O)=O |r| | N/A | 1 g | 1 | |
| 44 | BIDE PHARMATECH | BD88825 | 45 | CI-844 | O(c1ccccc1)c1cccnc1 | N/A | 250 mg | 1 |
| 45 | BIDE PHARMATECH | BD240019 | 133 | Antineoplaston AS2-5 Phenylacetylglutamine Sodium | NC(=O)CC[C@H](NC(=O)Cc1ccccc1)C(O)=O |r| | N/A | 1 g | 1 |
| 46 | BIDE PHARMATECH | BD630830 | 233 | Didox NSC-324360 | ONC(=O)c1ccc(O)c(O)c1 | N/A | 10 mg | 1 |
| 47 | BIDE PHARMATECH | BD166903 | 33 | Myristyl nicotinate Tetradecyl nicotinate Nia-114 | CCCCCCCCCCCCCCOC(=O)c1cccnc1 | N/A | 1 g | 1 |
| 48 | BIDE PHARMATECH | BD217175 | 150 | TS-011 | O\N=C\Nc1ccc(N2CCOCC2)c(Cl)c1 | N/A | 100 mg | 1 |
| 49 | BIDE PHARMATECH | BD306081 | 129 | BG KBG | OC1O[C@@H]2COC(O[C@H]2[C@H](O)[C@H]1O)c1ccccc1 |r| | N/A | 1 g | 1 |
| 50 | BIDE PHARMATECH | BD215173 | 7 | 5-Octanoylsalicylic acid beta-Lipohydroxy acid Effaclar k LHA | CCCCCCCC(=O)c1ccc(O)c(c1)C(O)=O | N/A | 1 g | 1 |
| 51 | BIDE PHARMATECH | BD627588 | 106 | CK-101 RX-518 | OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F | N/A | 25 mg | 1 |
| 52 | BIDE PHARMATECH | BD123838 | 32 | D-2083 DesOwen Desilux Desonate Tridesilon Verdeso Desonide (Prop INN; BAN; USAN) | CC1(C)O[C@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO |r,c:14,t:10| | N/A | 10 mg | 1 |
| 53 | BIDE PHARMATECH | BD628206 | 163 | AMAZ-02 Euro lysineiricin A Urolithin A | Oc1ccc2c(c1)oc(=O)c1cc(O)ccc21 | N/A | 10 mg | 1 |
| 54 | BIDE PHARMATECH | BD689265 | 178 | Ecamsule Ecamsulum (Prop INN) Mexoryl SX | [Na+].[Na+].CC1(C)C2CCC1(CS([O-])(=O)=O)C(=O)\C2=C/c1ccc(\C=C2/C3CCC(CS([O-])(=O)=O)(C2=O)C3(C)C)cc1 | N/A | 1 g | 1 |
| 55 | BIDE PHARMATECH | BD627730 | 244 | MP-513 Tenelia Tenglyn Teneligliptin hydrobromide hydrate (Prop INNM) | Br.Br.Br.Br.Br.Cc1cc(N2CCN(CC2)[C@@H]2CN[C@@H](C2)C(=O)N2CCSC2)n(n1)-c1ccccc1 |r| | N/A | 10 mg | 1 |
| 56 | BIDE PHARMATECH | BD764655 | 58 | CX-8998 MK-8998 | CC(C)c1ccc(CC(=O)N[C@H](C)c2ccc(OCC(F)(F)F)cn2)cc1 |r| | N/A | 10 mg | 1 |
| 57 | BIONET/Key Organics Ltd. | MS-0738 | 19 | 348U87 BW-348U87 | C\C(=N/NC(=S)NNC(=S)Nc1ccccc1Cl)c1ccccn1 | N/A | 10 mg | 1 |
| 58 | BIONET/Key Organics Ltd. | GE-0036 | 152 | PF-5 | CCCOCCn1c2cc(ncc2nc(N2CCN(CCO)CC2)c1=O)-c1ccc(OC)nc1 | N/A | 10 mg | 1 |
| 59 | BIONET/Key Organics Ltd. | SS-2975 | 63 | Org-30029 | Cl.COc1cc2cc(sc2cc1OC)C(\N)=N/O | N/A | 10 mg | 1 |
| 60 | BIONET/Key Organics Ltd. | ES-0040 | 1 | GPI-1046 | CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCc1cccnc1 |r| | N/A | 10 mg | 1 |
| 61 | BIONET/Key Organics Ltd. | KS-1366 | 203 | Ciclolysal Lymecycline Vebicyclysal Tetralysal | CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O |c:29,t:7| | N/A | 10 mg | 1 |
| 62 | BIONET/Key Organics Ltd. | DS-1313 | 121 | CMNa Sodium glycididazole | Cc1ncc(n1CCOC(=O)CN(CC(O)=O)CC(=O)OCCn1c(C)ncc1[N+]([O-])=O)[N+]([O-])=O | N/A | 1 g | 1 |
| 63 | BIONET/Key Organics Ltd. | EH-0718 | 41 | OC(=O)C1CCC(CC1)c1cc2cccnc2c(n1)-c1cccc(F)c1 | N/A | 10 mg | 1 | |
| 64 | Cayman Europe | 13620 | 223 | AL-6598 | CC(C)OC(=O)COC\C=C/C[C@H]1[C@H](Cl)C[C@@H](O)[C@@H]1CC[C@@H](O)C1CCCCC1 |r| | N/A | 10 mg | 1 |
| 65 | Cayman Europe | 75500 | 4 | 2315698 CPHPC GSK-2315698 Ro-63-8695 Miridesap (Prop INN) | OC(=O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(O)=O | N/A | 10 mg | 1 |
| 66 | Cayman Europe | 9002360 | 85 | MIV-150 | CCC(=O)c1ccc(F)c([C@@H]2C[C@@H]2NC(=O)Nc2ccc(cn2)C#N)c1O | N/A | 10 mg | 1 |
| 67 | Cayman Europe | 17805 | 27 | MDT-637 VP-14637 | Cc1nnnn1\N=C\c1ccc(O)c(c1)C(c1ccc(O)cc1)c1cc(\C=N/n2nnnc2C)ccc1O | N/A | 10 mg | 1 |
| 68 | Cayman Europe | 19673 | 47 | E-7046 ER-886046-00 | C[C@H](NC(=O)c1c(nn(C)c1Oc1cccc(c1)C(F)(F)F)C(F)F)c1ccc(cc1)C(O)=O | N/A | 10 mg | 1 |
| 69 | Cayman Europe | 20436 | 135 | DMAPT LC-1 NSC-734325 Dimethylaminoparthenolide | CN(C)C[C@@H]1[C@@H]2CC\C(C)=C/CC[C@@]3(C)O[C@@H]3[C@H]2OC1=O |c:9| | N/A | 10 mg | 1 |
| 70 | Cayman Europe | 21390 | 230 | 2838232 GSK-2838232 GSK-8232 | CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)Cc1ccc(Cl)cc1 |c:3| | N/A | 10 mg | 1 |
| 71 | Cayman Europe | 9002769 | 136 | Apoptone HE-3235 | C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C | N/A | 10 mg | 1 |
| 72 | Chem4Pharma | C4PST8 | 243 | 7-Keto 7-Keto DHEA 7-Keto dehydroepiandrosterone | CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3C(=O)C=C2C1 |c:24| | solid | 5 mg | 1 |
| 73 | ChemBridge Corporation | 5493356 | 120 | K-247 | OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C1O | solid | 10 mg | 1 |
| 74 | ChemDiv, Inc. | 4048-0266 | 196 | CCC(C)(C)c1ccc(OCCCCCCN2CCN(CC2)c2ccc(C)c(Cl)c2)cc1 | solid | 2 mg | 1 | |
| 75 | ChemDiv, Inc. | H025-0367C | 240 | PRX-07034 PRX-07034-001 | COc1cc(Cl)cc(C(C)Nc2cc(ccc2S(C)(=O)=O)N2CCNCC2)c1OC | solid | 10 mg | 1 |
| 76 | ChemFaces | CFN92033 | 122 | Delphinidin Delphinidin chloride Delphinidol Ephdine IdB-1056 | [Cl-].Oc1cc(O)c2cc(O)c([o+]c2c1)-c1cc(O)c(O)c(O)c1 | N/A | 10 mg | 1 |
| 77 | ChemFaces | CFN92038 | 215 | Delphinidin-3-glucoside Myrtillin | [Cl-].OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2cc(O)c(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O | N/A | 10 mg | 1 |
| 78 | ChemFaces | CFN90457 | 154 | (-)-Stepholidine l-Stepholidine l-SPD | COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(O)c4OC |r| | N/A | 20 mg | 1 |
| 79 | ChemFaces | CFN90152 | 186 | 11-Keto-beta-boswellic acid | C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)[C@@H]4[C@@]5(C)CC[C@@H](O)[C@@](C)([C@@H]5CC[C@@]34C)C(O)=O)[C@@H]2[C@H]1C |r,c:10| | N/A | 5 mg | 1 |
| 80 | ChemFaces | CFN90798 | 238 | (-)-Hydroxycitric acid Garcinia acid HCA | OC(C(O)=O)C(O)(CC(O)=O)C(O)=O | N/A | 5 mg | 1 |
| 81 | ChemFaces | CFN98048 | 109 | Lebanus Cedra | CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C |r| | N/A | 5 mg | 1 |
| 82 | ChemFaces | CFN93216 | 140 | Kukoamine B mesylate | NCCCN(CCCCNCCCNC(=O)CCc1ccc(O)c(O)c1)C(=O)CCc1ccc(O)c(O)c1 | N/A | 10 mg | 1 |
| 83 | ChemFaces | CFN92173 | 38 | Cyanidin 3-sambubioside Cyanidin 3-xyloglucoside Sambicyanin | [Cl-].OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)c(O)c2)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O |r| | N/A | 10 mg | 1 |
| 84 | ChemFaces | CFN92171 | 37 | Delphinidin-3-sambubioside | [Cl-].OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2cc(O)c(O)c(O)c2)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O |r| | N/A | 10 mg | 1 |
| 85 | ChemFaces | CFN00155 | 224 | Baogongteng A | CC(=O)O[C@@H]1C[C@@H]2N[C@H]1CC[C@H]2O |r| | N/A | 5 mg | 1 |
| 86 | EDASA Scientific | BB 0266169 | 84 | DITPA | OC(=O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1 | N/A | 250 mg | 1 |
| 87 | ENAMINE Ltd. | Z2213893411 | 117 | SM-108 | NC(=O)c1[nH]cnc1O | solid | 10 mg | 1 |
| 88 | ENAMINE Ltd. | EN300-35716 | 151 | MSF SNX-001 Methanesulfonyl fluoride | CS(F)(=O)=O | N/A | 250 mg | 1 |
| 89 | ENAMINE Ltd. | EN300-322394 | 234 | Dicarbamin Dicarbamine Glutaryl histamine Imidazolyl Ethanamide Pentandioic Acid IEPA Myelo-001 XC-55 Ingavirin | OC(=O)CCCC(=O)NCCc1cnc[nH]1 | N/A | 100 mg | 1 |
| 90 | ENAMINE Ltd. | Z31370920 | 212 | Centpropazine | CCC(=O)c1ccc(OCC(O)CN2CCN(CC2)c2ccccc2)cc1 | solid | 10 mg | 1 |
| 91 | ENAMINE Ltd. | EN300-67360 | 126 | 3-BrPA NSC-11731 NSC-62343 PSL-001 3-Bromopyruvate 3-Bromopyruvic acid | OC(=O)C(=O)CBr | N/A | 250 mg | 1 |
| 92 | ENAMINE Ltd. | Z1543480541 | 71 | Val-Tyr sardine peptidase | CC(C)C(N)C(=O)NC(Cc1ccc(O)cc1)C(O)=O | N/A | 10 mg | 1 |
| 93 | ENAMINE Ltd. | Z736926618 | 156 | Galodif Halodif meta-Chlorobenzhydryl urea | NC(=O)NC(c1ccccc1)c1cccc(Cl)c1 | N/A | 10 mg | 1 |
| 94 | ENAMINE Ltd. | EN300-697614 | 86 | Muconorm Reolase Telmesteine (Rec INN) YS-795 (as undefined isomer, lysine salt) | CCOC(=O)N1CSCC1C(O)=O | N/A | 250 mg | 1 |
| 95 | ENAMINE Ltd. | Z2153972216 | 74 | D-7042 D-7193 (as di-L-lysine salt) DiNac H-327/86 | CC(=O)N[C@@H](CSSC[C@H](NC(C)=O)C(O)=O)C(O)=O | N/A | 10 mg | 1 |
| 96 | ENAMINE Ltd. | EN300-332757 | 35 | Dapansutrile (Rec INN) OLT-1177 2Z03364G96 (UNII code) | CS(=O)(=O)CCC#N | N/A | 100 mg | 1 |
| 97 | ENAMINE Ltd. | Z164701248 | 11 | CH-170 Chinoin-170 | Cc1nc(Cn2cnc3n(C)c(=O)n(C)c(=O)c23)no1 | solid | 10 mg | 1 |
| 98 | ENAMINE Ltd. | Z1263714134 | 15 | A-429202 ABT-202 | Cl.Cl.NC1CCN(C1)c1cccnc1 | N/A | 10 mg | 1 |
| 99 | ENAMINE Ltd. | Z102844102 | 123 | RS-04 RS-0481 RS-481 | CC(NC(=O)C1CSCN1C(=O)c1ccccc1)c1ccccc1 | oil | 10 mg | 1 |
| 100 | ENAMINE Ltd. | Z1149820700 | 79 | NS-1 OCO-1112 | CC(C)c1ccc(cc1)C(=O)NCCOc1ccc(cc1)C(O)=O | solid | 10 mg | 1 |
| 101 | ENAMINE Ltd. | Z2301527375 | 108 | NSC-311056 TNO-6 Spiroplatin (USAN; BAN; Rec INN) | NCC1(CN)CCCCC1 | liquid | 10 mg | 1 |
| 102 | ENAMINE Ltd. | Z3245415702 | 111 | Elemene beta-Elemene SDP-111 | CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@@H](C1)C(C)=C |r| | N/A | 10 mg | 1 |
| 103 | ENAMINE Ltd. | Z317100312 | 190 | O=C1N(CCCN2CCN(CC2)c2ncccn2)S(=O)(=O)c2ccccc12 | solid | 10 mg | 1 | |
| 104 | ENAMINE Ltd. | Z82931631 | 193 | COc1cc(C=CC(=O)N2CCN(CC(=O)NC(C)C)CC2)cc(OC)c1OC |w:5.4| | solid | 10 mg | 1 | |
| 105 | ENAMINE Ltd. | EN300-74174 | 76 | DBFA | OC(=O)Cc1ccc2oc3ccccc3c2c1 | N/A | 100 mg | 1 |
| 106 | ENAMINE Ltd. | Z2327673241 | 93 | A-57219 Sch-40054 HCl Nemazoline hydrochloride (Rec INNM; USAN) | Nc1c(Cl)cc(CC2=NCCN2)cc1Cl |t:7| | solid | 10 mg | 1 |
| 107 | ENAMINE Ltd. | EN300-257275 | 176 | JTT-608 | CC1CCC(CC1)C(=O)CCC(O)=O | N/A | 100 mg | 1 |
| 108 | ENAMINE Ltd. | Z1474303724 | 138 | ANP-A10 Antineoplaston A10 Atengenal Cengenal | O=C(Cc1ccccc1)NC1CCC(=O)NC1=O | solid | 10 mg | 1 |
| 109 | ENAMINE Ltd. | Z1891775993 | 211 | Org-9768 | Cl.CC1(CN)Cc2ccccc2C1 | solid | 10 mg | 1 |
| 110 | ENAMINE Ltd. | Z1691545087 | 2 | Motapizone (Rec INN) NAT-5239 | CC1CC(=O)NN=C1c1cc(cs1)-n1ccnc1 |c:6| | N/A | 10 mg | 1 |
| 111 | ENAMINE Ltd. | Z1459454629 | 191 | Cl.Cl.COc1cc(N)c(Cl)cc1C(=O)N1CCN(Cc2ccc3OCOc3c2)CC1 | solid | 10 mg | 1 | |
| 112 | ENAMINE Ltd. | Z1154953662 | 182 | RX-71107 Tolmesoxide (BAN; Rec INN) | COc1cc(C)c(cc1OC)S(C)=O | N/A | 10 mg | 1 |
| 113 | ENAMINE Ltd. | Z1740753750 | 56 | PZG Pyrazinoylguanidine | Cl.Cl.NC(=N)NC(=O)c1cnccn1 | solid | 10 mg | 1 |
| 114 | ENAMINE Ltd. | EN300-197516 | 128 | MGBG Methyl-GAG PA-001 Win-10708-2 NSC-30609 (acetate) NSC-32946 (diHCl) Mitoguazone (DCF; DCIT; Rec INN) Zyrkamine | CC(C=NNC(N)=N)=NNC(N)=N |w:8.8,2.1| | N/A | 100 mg | 1 |
| 115 | ENAMINE Ltd. | Z2216718598 | 90 | VSN-16 VSN-16R | C[C@H](CO)NC(=O)c1cccc(C=CCCCC(=O)N(C)C)c1 |r,w:12.11| | N/A | 10 mg | 1 |
| 116 | ENAMINE Ltd. | Z2306534399 | 114 | Dimethynur | CNC(=O)N(C)N=O | solid | 10 mg | 1 |
| 117 | ENAMINE Ltd. | EN300-253077 | 187 | 4003/2 | CCOC(=O)c1ccccc1OC(N)=O | N/A | 100 mg | 1 |
| 118 | ENAMINE Ltd. | Z2306534385 | 237 | ADX-N05 ARL-N05 JZP-110 R-228060 SKL-N05 YKP-10A Solriamfetol (Prop INN) | NC(COC(N)=O)Cc1ccccc1 | solid | 10 mg | 1 |
| 119 | ENAMINE Ltd. | Z2306534444 | 87 | IQB-782 | NC(=N)NC(CS)C(O)=O | solid | 10 mg | 1 |
| 120 | ENAMINE Ltd. | Z1441684043 | 161 | PF-219061 | CCCN1CCOC(C1)c1cccc(O)c1 | N/A | 10 mg | 1 |
| 121 | ENAMINE Ltd. | Z2895081069 | 195 | Fc1ccc(cc1)C(CCCN1CCN(CCNc2ccccc2)CC1)c1ccc(F)cc1 | N/A | 10 mg | 1 | |
| 122 | ENAMINE Ltd. | EN300-742040 | 155 | Carisbamate (Prop INN; USAN) Comfyde JNJ-10234094 RWJ-333369 YKP-509 | NC(=O)OCC(O)c1ccccc1Cl | N/A | 100 mg | 1 |
| 123 | FCH Group | FCG2306924189 | 179 | NS-8 | Cc1c([nH]c(N)c1C#N)-c1ccccc1F | N/A | 10 mg | 1 |
| 124 | FCH Group | FCG2328062892 | 59 | Picartamide RP-40749 | CNC(=S)C1(CCCS1)c1ccccn1 | N/A | 10 mg | 1 |
| 125 | FCH Group | FCG53189703 | 17 | DQ-2511 Ecabamide Ecabapide (Rec INN) Muralis | CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1 | N/A | 10 mg | 1 |
| 126 | FCH Group | FCG1533140509 | 232 | NDD-094 SDZ-NDD-094 | Cc1nccn1Cc1ccccn1 | N/A | 10 mg | 1 |
| 127 | FCH Group | FCG741712541 | 218 | JNJ-26990990 | NS(=O)(=O)NCc1csc2ccccc12 | N/A | 10 mg | 1 |
| 128 | FCH Group | FCG2306924263 | 116 | Clomesone NSC-338947 | CS(=O)(=O)CS(=O)(=O)OCCCl | N/A | 10 mg | 1 |
| 129 | FCH Group | FCG2467601015 | 81 | LCB-2183 | CCOCc1nc2nccnc2c(=O)[nH]1 | N/A | 10 mg | 1 |
| 130 | Fluorochem (made-to-order) | 240789 | 166 | Isoflavone | O=c1c(coc2ccccc12)-c1ccccc1 | N/A | 250 mg | 1 |
| 131 | Fluorochem (made-to-order) | 079507 | 104 | Amtolmetin guacil (Rec INN) Eufans MED-15 ST-679 | COc1ccccc1OC(=O)CNC(=O)Cc1ccc(C(=O)c2ccc(C)cc2)n1C | N/A | 250 mg | 1 |
| 132 | Fluorochem (made-to-order) | 533531 | 89 | G-4544 NSC-15200 Gallium nitrate (USAN) Ganite | O.[Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O | N/A | 10 g | 1 |
| 133 | Fluorochem (made-to-order) | 542358 | 31 | 2894512 GSK-2894512 WB-1001 WBI-1001 84HW7D0V04 (UNII code) Benvitimod Tapinarof (Prop INN; USAN) | CC(C)c1c(O)cc(C=Cc2ccccc2)cc1O |w:8.7| | N/A | 250 mg | 1 |
| 134 | InterBioScreen Ltd. | STOCK1N-34915 | 236 | FCE-22250 | CO[C@H]1\C=C\OC2(C)Oc3c(C2=O)c2c(O)c(\C=N\N=C\N4CCCCC4)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@H](O)[C@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C |r,c:34,t:3,36| | N/A | 10 mg | 1 |
| 135 | InterBioScreen Ltd. | STOCK1N-12199 | 201 | CC1C[C@@]2(C)C(CCC3C4CCC(O)[C@@]4(C)CCC23)C\C1=N\N=C1/CC2CCC3C4CCC(O)[C@@]4(C)CCC3[C@@]2(C)CC1C |r| | N/A | 10 mg | 1 | |
| 136 | InterBioScreen Ltd. | STOCK1N-97577 | 107 | NSC-68075 Thaliblastine Thalicarpine | COc1cc(CC2N(C)CCc3cc(OC)c(OC)cc23)c(Oc2cc3CC4N(C)CCc5cc(OC)c(OC)c(-c3cc2OC)c45)cc1OC | N/A | 10 mg | 1 |
| 137 | InterBioScreen Ltd. | STOCK1N-17290 | 132 | AOX APC-100 CPC-100 Chromane C1 NSC-226236 PMCol | Cc1c(C)c2OC(C)(C)CCc2c(C)c1O | N/A | 10 mg | 1 |
| 138 | InterBioScreen Ltd. | STOCK1N-65562 | 162 | Mesterolone (BAN; USAN; Rec INN) NSC-75054 SH-723 Pro-Viron | C[C@H]1CC(=O)C[C@@H]2CC[C@H]3C4CC[C@H](O)[C@@]4(C)CCC3[C@@]12C |r| | N/A | 10 mg | 1 |
| 139 | InterBioScreen Ltd. | STOCK1N-17178 | 65 | Cytaphat Cytisin amidophosphate O,O-Dimethyl-N-cytinizylphosphate | COP(=O)(OC)N1C[C@H]2C[C@H](C1)c1cccc(=O)n1C2 |r| | N/A | 10 mg | 1 |
| 140 | Labseeker (made-to-order) | SC-43896 | 78 | Tributyrin | CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC | N/A | 1 kg | 1 |
| 141 | Labseeker (made-to-order) | SC-43634 | 144 | AC-7739 AVE-8063 AVE-8063A CS-39.HCl RPR-258063A ST-3100 | COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1N | N/A | 1 g | 1 |
| 142 | Labseeker (made-to-order) | SC-18976 | 137 | AEC Alpharen Fermagate (Prop INN) | [OH-].[OH-].[OH-].[Fe+3] | N/A | 500 g | 1 |
| 143 | Life Chemicals Inc. | F2147-2995 | 26 | Ampion Aspartyl-alanyl-diketopiperazine DA-DKP DMI-9523 | C[C@@H]1NC(=O)[C@H](CC(O)=O)NC1=O |r| | solid | 10 mg | 1 |
| 144 | Life Chemicals Inc. | F9994-0697 | 124 | 2-HB 2-HOBA Salicylamine | Cl.NCc1ccccc1O | solid | 250 mg | 1 |
| 145 | Life Chemicals Inc. | F2145-0456 | 94 | F-0930-RS Lerisetron (Rec INN) | C(c1ccccc1)n1c(nc2ccccc12)N1CCNCC1 | solid | 10 mg | 1 |
| 146 | Life Chemicals Inc. | F1907-2371 | 214 | Centpiperalone | Cl.Cl.O=c1[nH]c(nc2ccccc12)N1CCNCC1 | solid | 10 mg | 1 |
| 147 | Life Chemicals Inc. | F6492-0153 | 95 | KAE-393 YM-114 | O=C(C1CCc2[nH]cnc2C1)N1CCc2ccccc12 | solid | 10 mg | 1 |
| 148 | Life Chemicals Inc. | F9994-5209 | 118 | 589C 589C80 BW-A589C Tucaresol (BAN; Rec INN) | OC(=O)c1ccc(COc2cccc(O)c2C=O)cc1 | solid | 10 mg | 1 |
| 149 | Manchester Organics | T45971 | 51 | 2,3-cis/exo-Camphanediol | CC1(C)[C@@H]2CC[C@@]1(C)[C@H](O)[C@@H]2O |r| | N/A | 5 g | 1 |
| 150 | Manchester Organics | K18931 | 159 | B-GYKI-38233 GYKI-38233 TYB-3823 Restacorin | Cl.CN(C)C(=N)NNc1c(C)cccc1C | N/A | 0.5 g | 1 |
| 151 | Maybridge, Ltd. | NRB03732 | 29 | VBP-15 8XP29XMB43 (UNII code) Vamorolone (Prop INN) Verolone | C[C@@H]1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)[C@@]1(O)C(=O)CO |r,c:11,17,t:7| | N/A | 10 mg | 1 |
| 152 | Otava made to order | 5414954 | 55 | [123I]-BZA [123I]-IDAB | CCN(CC)CCNC(=O)c1ccc(I)cc1 | N/A | 50 mg | 1 |
| 153 | Otava made to order | 4514543 | 227 | FK-962 | CC(=O)N1CCC(CC1)NC(=O)c1ccc(F)cc1 | N/A | 50 mg | 1 |
| 154 | Otava, Ltd. | 2630816 | 9 | MDL-27531 | Cn1c(nnc1S(C)(=O)=O)-c1ccccc1 | solid | 10 mg | 1 |
| 155 | Otava, Ltd. | 2484583 | 217 | W-2719 | OCCCCSc1ccc(Cl)cc1 | solid | 10 mg | 1 |
| 156 | Otava, Ltd. | 7070707145 | 30 | K-10191 K-604 | CSc1cc(C)nc(SC)c1NC(=O)CN1CCN(CCSc2nc3ccccc3[nH]2)CC1 | solid | 3 mg | 1 |
| 157 | Otava, Ltd. | 4112434 | 21 | F-2692 | Cl.Cc1cc(=O)c(N)nn1-c1cccc(c1)C(F)(F)F | solid | 10 mg | 1 |
| 158 | Otava, Ltd. | 7614358 | 99 | Cl.OC(=O)C1CC(CN1)Oc1cccc(Cl)c1 | solid | 10 mg | 1 | |
| 159 | Otava, Ltd. | 9253222 | 66 | Hoe-077 Lufironil (USAN; Rec INN) | COCCNC(=O)c1ccnc(c1)C(=O)NCCOC | N/A | 10 mg | 1 |
| 160 | PBMR Labs Ukraine | RBK_070824 | 22 | CGS-8216 | O=c1n([nH]c2c1cnc1ccccc21)-c1ccccc1 | N/A | 1 g | 1 |
| 161 | Pharmeks, Ltd. | PHAR103239 | 14 | Dalargin | OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(CCCNC(N)=N)C(O)=O | N/A | 10 mg | 1 |
| 162 | Ramidus AB | RAM0215 | 61 | Bay-y-5959 | CC(C)OC(=O)C1=C(N)NC(C)=C(C#N)C1c1cccc2ncc(cc12)-c1ccccc1 |c:6,t:11| | N/A | 50 mg | 1 |
| 163 | Ramidus AB | RAM0272 | 100 | CGP-29030A | COc1cc(OC)cc(c1)C(=O)N1CCN(CCc2ccc(Cl)cc2)CC1 | N/A | 50 mg | 1 |
| 164 | Ramidus AB | RAM2557 | 149 | Ipazilide fumarate (Rec INNM; USAN) Win-54177-4 | CCN(CC)CCCNC(=O)Cn1ncc(c1-c1ccccc1)-c1ccccc1 | N/A | 50 mg | 1 |
| 165 | Ramidus AB | RAM2571 | 213 | DU-29373 Flesinoxan hydrochloride (Rec INNM) | [Cl-].OCC1COc2c(O1)cccc2N1CC[NH+](CCNC(=O)c2ccc(F)cc2)CC1 | N/A | 50 mg | 1 |
| 166 | Ramidus AB | RAM3091 | 170 | L-702958 | CS(=O)(=O)Nc1ccc2OC3(CCN(CC3)C3CCc4cc(ccc4C3)C#N)CC(=O)c2c1 | N/A | 50 mg | 1 |
| 167 | Selleck Chemicals LLC | S4075 | 222 | Pyrithione Zinc (Prop INN; BAN) Zinc pyrithione Zinc Omadine ZnP ZnPy | O1N2C=CC=CC2=[S][Zn]11ON2C=CC=CC2=[S]1 |c:2,4,7,13,15,18| | N/A | 50 mg | 1 |
| 168 | Specs | CS-004/04003052 | 18 | Bonaphthone | Brc1ccc2C(=O)C(=O)C=Cc2c1 |c:9| | N/A | 10 mg | 1 |
| 169 | Specs | AE-641/00603053 | 185 | RS-49014 Tazifylline hydrochloride (Rec INNM; USAN) | Cn1c2ncn(CC(O)CN3CCN(CCCSc4ccccc4)CC3)c2c(=O)n(C)c1=O | N/A | 5 mg | 1 |
| 170 | Specs | AE-641/30115022 | 3 | Isofloxythepin | CC(C)c1ccc2Sc3cc(F)ccc3CC(N3CCN(CCO)CC3)c2c1 | N/A | 2 mg | 1 |
| 171 | Specs | AE-641/00359018 | 210 | Moxifetin hydrogen maleate VUFB-15468 | CN(C)Cc1ccccc1Sc1cccc(O)c1 | N/A | 5 mg | 1 |
| 172 | Specs | AE-641/11067058 | 43 | Brovincamine fumarate (Rec INNM) Sabromin | CCC12CCCN3CCc4c(C13)n(c1cc(Br)ccc41)C(O)(C2)C(=O)OC | N/A | 5 mg | 1 |
| 173 | SpiroChem | SPC-h492 | 80 | OCc1cncc(F)c1 | N/A | 1 g | 1 | |
| 174 | SpiroChem | SPC-s656 | 8 | GSK-1482160 | CN1[C@H](CCC1=O)C(=O)NCc1cccc(c1Cl)C(F)(F)F | N/A | 0.1 g | 1 |
| 175 | SynChem Inc | SC-02132 | 103 | Capsavanil Davasaicin (Rec INN) KR-25018 DA-5018 (monohydrochloride) | COc1cc(CC(=O)NCCCc2ccc(C)c(C)c2)ccc1OCCN | N/A | 10 mg | 1 |
| 176 | SynChem Inc | SC-36020 | 50 | P414 SNAC E414 (free acid) Salcaprozate sodium (USAN) Salcaprozic acid sodium salt (Rec INNM; USAN) | [Na+].Oc1ccccc1C(=O)NCCCCCCCC([O-])=O | N/A | 250 mg | 1 |
| 177 | SynQuest Laboratories, Inc. | 2H12-3-07 | 54 | 18F-FDG FDG [18F]FDG [F-18]-FDG Flucis Fludeoxyglucose F18 Fludeoxyglucose (18F) (Prop INN) [18F]Fludeoxyglucose | OC[C@H]1OC(O)[C@@H](F)[C@@H](O)[C@@H]1O |r| | N/A | 10 mg | 1 |
| 178 | TargetMol | T0543 | 92 | 7-Methylxanthine | Cn1cnc2[nH]c(=O)[nH]c(=O)c12 | N/A | 10 mg | 1 |
| 179 | TargetMol | T6430 | 160 | 25-Hydroxycholecalciferol 25-Hydroxyvitamin D3 Calcidiol Calcifediol (Prop INN) 25-OH-D3 CTAP-101 Ro-8-8892 U-32070E Dedrogyl Rayaldee Rayaldy Replidea | C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C | N/A | 10 mg | 1 |
| 180 | TargetMol | T3497 | 5 | Ocaperidone (BAN; USAN; Rec INN) R-79598 | Cc1cccn2c1nc(C)c(CCN1CCC(CC1)c1noc3cc(F)ccc13)c2=O | N/A | 10 mg | 1 |
| 181 | TargetMol | T4040 | 220 | AN-2718 | OB1OCc2cc(Cl)ccc12 | N/A | 10 mg | 1 |
| 182 | TargetMol | T3547 | 175 | LP-802034 LX-4211 SAR-439954 Sotagliflozin (USAN; Rec INN) | CCOc1ccc(Cc2cc(ccc2Cl)C2OC(SC)C(O)C(O)C2O)cc1 | N/A | 10 mg | 1 |
| 183 | TargetMol | T2316 | 177 | Denagliptin tosilate (USAN; Rec INN) GW-823093C | CS(=O)(=O)n1cc2CN(Cc2n1)C1COC(C(N)C1)c1cc(F)ccc1F | N/A | 10 mg | 1 |
| 184 | TargetMol | T3184 | 88 | Kevetrin Thioureidobutyronitrile hydrochloride | Cl.NC(=N)SCCCC#N | N/A | 10 mg | 1 |
| 185 | TargetMol | T3274 | 146 | S-49076 (free base) | O=C1CSC(=O)N1Cc1ccc2NC(=O)\C(=C/c3cc(CN4CCOCC4)c[nH]3)c2c1 | N/A | 10 mg | 1 |
| 186 | TargetMol | T4168 | 206 | Plastomitin Visomitin SkQ1 | [Br-].CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O |c:1,38| | N/A | 10 mg | 1 |
| 187 | TargetMol | T3157 | 147 | COH-29 | Oc1ccc(cc1O)C(=O)Nc1nc(c(s1)-c1ccccc1)-c1ccc(O)c(O)c1 | N/A | 10 mg | 1 |
| 188 | TargetMol | T3480 | 172 | LL-3858 Sudoterb | Cc1c(CN2CCN(CC2)c2cccc(c2)C(F)(F)F)cc(-c2ccccc2)n1NC(=O)c1ccncc1 | N/A | 10 mg | 1 |
| 189 | TargetMol | T3485 | 112 | AT-2153 MST-02 Probimane | CC(CN1CC(=O)N(CN2CCOCC2)C(=O)C1)N1CC(=O)N(CN2CCOCC2)C(=O)C1 | N/A | 10 mg | 1 |
| 190 | TargetMol | T3472 | 188 | CGS-27023 | Cl.COc1ccc(cc1)S(=O)(=O)N(Cc1cccnc1)C(C(C)C)C(=O)NO | N/A | 10 mg | 1 |
| 191 | TargetMol | T7003 | 46 | L-MTx LMT-X Leuco-MTx TRX-0237 LMTX Leuco methylthioninium salt | CS([O-])(=O)=O.CS([O-])(=O)=O.C[NH+](C)c1ccc2Nc3ccc(cc3Sc2c1)[NH+](C)C | N/A | 10 mg | 1 |
| 192 | Tocris Bioscience | 2423 | 226 | Adaptavir D-Ala1-peptide T-NH2 DAPTA RAP-101 | C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O | N/A | 1 mg | 1 |
| 193 | UkrOrgSynthesis | BBV-266458 | 181 | AM-24 BOBEL-24 BOBEL-246 TIP | Oc1c(I)cc(I)cc1I | N/A | 1 g | 1 |
| 194 | UkrOrgSynthesis | BBV-51874600 | 208 | EG-030 MRZ-99030 | Cl.CC(C)(NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(O)=O | N/A | 1 g | 1 |
| 195 | UkrOrgSynthesis | BBV-49705896 | 20 | Amitivir sodium (Rec INNM) LY-253963 | N#CNc1nncs1 | N/A | 1 g | 1 |
| 196 | UkrOrgSynthesis | PB2297922485 | 10 | DF-1012 | CN1C2CCC1CC(C2)NC(=O)c1c[nH]c2ncccc12 |THB:0:1:3.4:6.7.8| | N/A | 10 mg | 1 |
| 197 | UkrOrgSynthesis Ltd. Stock | PB56841813 | 16 | AD-2646 AS-2646 | OC(=O)C(O)=O.OC(=O)C(O)=O.CCN1CCN(CC1)c1cc(-c2ccccc2)c2ccccc2n1 | solid | 10 mg | 1 |
| 198 | UkrOrgSynthesis Ltd. Stock | PB31329768 | 235 | AQ-13 | CCN(CC)CCCNc1ccnc2cc(Cl)ccc12 | solid | 10 mg | 1 |
| 199 | UkrOrgSynthesis Ltd. Stock | PB2379257047 | 102 | ARL-12495 FPL-12495 AR-R12495AA (monoHCl) ARL-12495AA (monoHCl) | CC(N)(Cc1ccccc1)c1ccccc1 | N/A | 10 mg | 1 |
| 200 | UkrOrgSynthesis Ltd. Stock | PB1736739541 | 24 | Bromantan Bromantane Ladasten | Brc1ccc(NC2C3CC4CC(C3)CC2C4)cc1 | solid | 10 mg | 1 |
| 201 | UkrOrgSynthesis Ltd. Stock | PB2327961309 | 44 | 7-MEOTA 7-Methoxytacrine | COc1ccc2nc3CCCCc3c(N)c2c1 | N/A | 10 mg | 1 |
| 202 | UkrOrgSynthesis Ltd. Stock | PB2301612965 | 153 | TAT WP-921 | OC(=O)Cn1nnnc1-c1ccsc1 | N/A | 10 mg | 1 |
| 203 | Vitas-M Laboratory, Ltd. | STL069536 | 145 | HE-11 Nibentan | CCN(CC)CCCCC(NC(=O)c1ccc(cc1)[N+]([O-])=O)c1ccccc1 | solid | 10 mg | 1 |
| 204 | Vitas-M Laboratory, Ltd. | STL146549 | 115 | NMF | CNC=O | solid | 10 mg | 1 |
| 205 | Vitas-M Laboratory, Ltd. | STK510029 | 113 | DM-COOK CB-10-277 (free acid) | CN(C)\N=N\c1ccc(cc1)C(O)=O | solid | 10 mg | 1 |
| 206 | Vitas-M Laboratory, Ltd. (Premium) | STK365651 | 119 | K-MAP | OCC1OC(Nc2ccc(cc2)C(O)=O)C(O)C(O)C1O | solid | 10 mg | 1 |
| 207 | Vitas-M Laboratory, Ltd. (Premium) | STK409432 | 198 | OC(=O)Cn1cc(I)c(=O)c(I)c1 | solid | 10 mg | 1 | |
| 208 | Vitas-M Laboratory, Ltd. (Premium) | STK995917 | 157 | Etacizin Ethacizin NIK-244 | CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN(CC)CC)c2c1 | solid | 10 mg | 1 |
| 209 | Vitas-M Laboratory, Ltd. (Premium) | STK325026 | 130 | Depogen Drotaverine acephyllinate | CCOc1ccc(\C=C2\NCCc3cc(OCC)c(OCC)cc23)cc1OCC | solid | 10 mg | 1 |
| 210 | Vitas-M Laboratory, Ltd. (Premium) | STK379708 | 52 | TU-2100 | CCOC(=O)c1ccccc1OC(=O)CCCCCCCC(=O)Oc1ccccc1C(=O)OCC | solid | 10 mg | 1 |
| 211 | Vitas-M Laboratory, Ltd. (Premium) | STK279680 | 221 | Riodoxol | Oc1c(I)cc(I)c(O)c1I | solid | 10 mg | 1 |
| 212 | Vitas-M Laboratory, Ltd. (Premium) | STK060728 | 173 | Perchlozone | NC(=S)N\N=C\c1ccncc1 | solid | 10 mg | 1 |
| 213 | Vitas-M Laboratory, Ltd. (Premium) | STK134741 | 101 | SCP-1 | Oc1ccc(NC(=O)CN2C(=O)c3ccccc3S2(=O)=O)cc1 | solid | 10 mg | 1 |
| 214 | Vitas-M Laboratory, Ltd. (Premium) | STK693348 | 229 | AzddMeCyd CS-92 | Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)nc1N | solid | 10 mg | 1 |
| 215 | Vitas-M Laboratory, Ltd. (Premium) | STL371145 | 165 | BH-6 Obidoxime Obidoxime chloride (USAN) Toksobidin Toxogonin | O\N=C\c1cc[n+](COC[n+]2ccc(\C=N\O)cc2)cc1 | solid | 10 mg | 1 |
| 216 | Vitas-M Laboratory, Ltd. (Premium) | STL434975 | 148 | ECyd SB-596168 TAS-106 Ethynylcytidine | Nc1ccn(C2OC(CO)C(O)(C#C)C2O)c(=O)n1 | solid | 10 mg | 1 |
File details come from the government source that posted it.